c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: Incidence, mechanisms, and clinical significance

Modern Pathology

Volumn 15, Issue 4, 2002, Pages 462-469

  Schleger, C ^a   Verbeke, C ^b   Hildenbrand, R ^a   Zentgraf, H ^c   Bleyl, U ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Amplification; C MYC; FISH; Overexpression; Pancreatic cancer; PanIN

Indexed keywords

MYC PROTEIN;

ARTICLE; CANCER GRADING; CANCER STAGING; CENTROMERE; CHROMOSOME 8Q; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; ONCOGENE C MYC; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; DATA INTERPRETATION, STATISTICAL; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 0036229486     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880547     Document Type: Article

References (27)

1. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective
2. Molecular pattern of ductal pancreatic cancer
3. Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridisation (CGH)
4. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer
5. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma
6. Cytogenetic analysis of pancreatic carcinomas: Intratumour heterogeneity and nonrandom pattern of chromosome aberrations
7. The myc oncogene: Its role in transformation and differentiation
8. The role of c-myc in cell growth
9. Amplification of cellular oncogenes: A predictor of the clinical outcome in human cancer
10. Role of myc amplification and overexpression in cell growth, differentiation and death
11. MYC oncogenes and human neoplastic disease
12. Amplifications of both c-Ki-ras with a point mutation and c-myc in primary pancreatic cancer and its metastatic tumours in lymph nodes
13. Oncogenes in cancer of the pancreas
14. Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: Basic findings and clinical aspects
15. Pathology of nonendocrine pancreas tumours
16. Ultra-sensitive FISH using peroxidase-mediated deposition of biotin- or fiuorochrome tyramides
17. Pancreatic intraepithelial neoplasia. A new nomenclature and classification system for pancreatic duct lesions
18. FISH analysis of interphase nuclei extracted from paraffin-embedded tissue
19. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung
20. C-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization
21. Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer
22. MYC function and regulation
23. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene
24. Expression of the myc gene family in different stages of human colorectal cancer
25. Over-expression and amplification of the c-myc gene in human urothelial carcinoma
26. Aggressive subtypes of human colorectal tumours frequently exhibit amplification of the c-myc gene
27. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation